D-chiro-inositol and Endometrial Thickness
Not Applicable
Completed
- Conditions
- Endometrial Diseases
- Registration Number
- NCT05283642
- Lead Sponsor
- Lo.Li.Pharma s.r.l
- Brief Summary
Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 13
Inclusion Criteria
- altered endometrial thickness
Exclusion Criteria
- patients with cancer
- patients under hormonal treatments (progestogens and/or estrogens)
- patients supplemented with inositols
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change in endometrial thickness Two time points: baseline and after three months Change in endometrial thickness by ultrasound measurement from baseline to three months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does D-chiro-inositol utilize to influence endometrial thickness in women with endometrial diseases?
How does D-chiro-inositol supplementation compare to standard-of-care treatments for altered endometrial thickness in reproductive health?
Are there specific biomarkers associated with endometrial thickness response to D-chiro-inositol in clinical trials?
What adverse events have been reported with D-chiro-inositol use in endometrial disease studies, and how are they managed?
What are the potential combination therapies involving D-chiro-inositol for endometrial thickness modulation in patients with hormonal imbalances?
Trial Locations
- Locations (1)
ASL Umbria 2
🇮🇹Terni, Umbria, Italy
ASL Umbria 2🇮🇹Terni, Umbria, Italy